Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care

Summary

Newronika S.p.A. received CE Mark certification for its commercial αDBS adaptive deep brain stimulation system, the first such approval in the European Economic Area for a device that continuously senses local field potentials and automatically adjusts stimulation while integrating with the WebBioBank neural data platform. The milestone supports personalized therapy for Parkinson’s disease with fewer side effects and clinical visits.